Trial NCT02353780

View at ClinicalTrials.gov 
Org. Study IDs: STUDY19040127

Last trial update was posted on 2020-10-01

MeSH Interventions

Abatacept Certolizumab Pegol Etanercept Infliximab Tumor Necrosis Factor Inhibitors

MeSH Conditions

Arthritis Arthritis, Rheumatoid

Other Conditions

Rheumatoid Arthritis (RA)

Stopping Reasons

Low enrollment

Limitations And Caveats

Due to the small number of patients enrolled in each group, it was not possible to perform statistical analyses of the primary endpoints. These are fairly broad measures that require large numbers to identify patterns in subset changes.

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID